After six months, were really not seeing a real diminution in anabody levels. People who do get coved, you know, in that range, usually o're not very sick at all. But certainly over six months, or if youre amino compromise, then the benefit really outweighs that. There are a number of patients who are cutting the line. Anda, or, this is why it's somewhat confusing. We've got a group of people are very aggressive, and the pharmacys really don't have the resources to double check,. Are you really am compromise o? So there really ar options. Monoclonal anabodies are available. The really, hopefully
Dr. Ian Lustbader, Clinical Professor of Medicine at the NYU School of Medicine, discusses the virus, vaccines and variants. Bloomberg's Ira Boudway looks at how the MLB Tests Robot Umps, New Rules to Fix Baseball Boredom Problem. Bloomberg's Sonali Basak details Five Traders on how to Survive Disrupted Markets. Brian Chappatta, Bloomberg Opinion Columnist, on how KKR Succession Is Watershed for Private Equity. And we Drive to the Close with Randy Watts, Chief Investment Strategist at O'Neil Global Advisors Hosts: Carol Massar and Tim Stenovec. Producer: Charlie Vollmer
See omnystudio.com/listener for privacy information.